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INTRODUCTION 
 1 
INTRODUCTION 
 
Pre-eclampsia (PE), a non-convulsive form of hypertensive 
disorders complicating pregnanacy, accounts for a significant proportion 
of morbidity as well as death in both mother & foetus.[1] 
The incidence of preeclampsia ranges from 5-15%. In India the 
prevalence rate of preeclampsia has been found out to be 8-10% of total 
number of pregnancies. The incidence in primigravidae is about 10% and 
in multigravidae about 5%(2).. Based on the norms of American college of 
obstetrics & Gynecologist, the diagnostic criteria for hypertensive 
disorders complicating pregnancy is a) The value of systolic Blood 
pressure being more than or equal to140 mmHg b) the value of diastolic 
pressure being more than or equal to 90 mmHg Or 3) a rise of  ≥ 30 mm/Hg in 
the value of systolic pressure Or 4) increase of ≥ 15 mmHg in Diastolic 
pressure, recorded in a female whose prior blood pressure has been 
normal . 
It has been noted that the preeclampsia generally begins after 
20weeks of gestation.A rise in blood pressure of more than 140/90mmhg 
along with proteinuria (either twenty four hour urine protein value being 
more than 300mg or a dipstick test which is positive with a value of 
30mg/dl) is considered as the definition for preeclampsia. Preeclampsia is 
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characterized by vasospasam,increased peripheral vascular resistance,and 
reduced organ perfusion. The essential pathophysiology of preeclampsia 
has been noted as the elevated blood pressure which is resulting from the 
vasospastic mechanism occuring in human organs such as kidney, 
pregnant uterus, placenta & brain. Abnormalities of lipid production 
could result in a low ratio of PGI2: TXA2(3). This has also been 
considered as one of the significant mechanism of increased blood 
pressure  occuring in pregnancy. Alteration in lipid production and its 
metabolic pathway has a prominent role in hypertensive disorders 
complicating pregnancy 
Inspite of the on going research works,the causative factors 
responsible for the incidence of preeclampsia could not be identified 
properly. Moreover, it has not been possible to find out a single test that 
can identify the females who are prone for developing preeclampsia(4). 
The incidence of preeclampsia has been observed to be higher if 
abnormal lipid metabolism occurs in initial phase of gestation  Lipid 
profile in females having a history of  preeclampsia is found out to 
significantly distinct from that of females with normal gestation(5). 
Abnormalities in the lipid metabolic pathway have been observed as an 
important factor resulting in the increased blood pressure & proteinuria 
that occur in preeclampsia. Disorders of lipoprotein metabolism are 
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reported to be a major cause of hypertension and proteinuria in Pre-
eclampsia(6,7,8). Inview of the above mentioned observations,it has been 
suggested  that the abnormalities of lipid synthesis and its metabolic 
pathway might play a significant part in the occurence of features of Pre-
eclampsia and Eclampsia. Our study has been carried out to understand 
the various abnormalities of lipid parameters   in pregnant mothers 
presenting with pre-eclampsia. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
AIMS AND OBJECTIVES 
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AIM AND OBJECTIVES 
 
1. To study the lipid profile in pre eclampsia 
2. To explore the possibility of dyslipidemia in the pathogenesis of 
preeclampsia. 
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REVIEW OF LITERATURE 
 
PLASMA LIPIDS AND LIPOPROTEIN METABOLISM 
Plasma Lipids 
Lipids are seen in the following forms: 
1. Fatty acids - straight chain compounds of varying lengths. 
2. Triglycerides - consist of glycerol and 3 fatty acids. 
3. Phospholipids - complex lipids, similar to TG but containing 
phosphate and a nitrogenous base.  
The major phospholipids seen in plasma are lecithin and 
sphingomyelin. The phosphates and nitrogenous bases are soluble in 
water, which is an important quality for lipid transport. Cholesterol is 
having steroid structure, and all the other steroids are derived from it. In 
plasma 2/3 rd of the cholesterol exist esterified with FA as   cholesterol 
esters. 
 
LIPOPROTEINS 
Lipids are partially soluble in water, to be carried in the body fluids 
they complexes with protein to form water soluble lipoprotein. 
The water soluble part of protein, phospholipids and free 
cholesterol enclose a core of insoluble cholesterol esters and triglycerides.  
They are classified according to their densities into four main types. 
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Two are important for cholesterol transport : 
1. HDL (High density lipoprotein) which transports cholesterol 
from peripheral tissues. 
2. LDL (Low density lipoprotein) transports cholesterol to 
peripheral tissues. 
Other Two groups are important for TGL transport: 
• VLDL (Very Low Density Lipoproteins) - transport endogenous 
triglyceride from the liver to peripheral tissues. 
• Chylomicrons transport exogenous (dietary) triglycerides from gut 
to the liver. 
A 5th Class also exist, IDL (Intermediate Density Lipoprotein) 
which is  a transient intermediate in the metabolism of VLDL to LDL .  
Plasma taken from a fasting subject contains only HDL, LDL and 
VLDL. 
 
 
 
 
 
 
STRUCTURE OF LIPOPROTEIN 
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Chylomicrons 
Chylomicrons serve as the carrier for the transport of dietary lipids 
in the plasma. They are synthesised iniside the enterocytes from the 
packaging of fat droplets .they are rich in triglycerides. When they are 
formed they contain onlyI apoB-48, apoA-I, apoA-II, and apoA-IV but 
later apo-C and apo- E are added from HDL. Their function is to transport 
dietary triglycerides from intestine to the adipose tissues for storage and 
to muscle and heart for their energy requirements. This exchange  with 
HDL is important for subsequent lipolysis of chylomicrons by lipoprotein 
lipase (LPL) as apoE is needed for chylomicron binding to the endothelial 
surface and apoC-II is essential for activation of LPL(2). When mature 
chylomicron reaches the capillary networks perfusing the muscle and 
adipose tissues, they bind with endothelial surface through their apo-E. 
This binding result in interaction of chylomicrons with the endothelial 
LPL and its activation by apoC-II. LPL causes hydrolysis of the 
triglyceride content of chylomicrons and release of free fatty acids inside 
the capillaries. The major part of fatty acids released, diffuse into the 
adjacent myocytes for energy production or into adipocytes for storage.(2) 
The remaining part is called as  chylomicron remnants, apoC and apoE 
exchanged back to HDL before their removal from the circulation by the 
liver and other tissues via LDL receptor-related protein (LRP). 
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VLDL, IDL, and LDL 
VLDL particles are synthesized by the liver and serve as the 
vehicle for transport of endogenous lipids to the peripheral tissues. 
Nascent VLDL is formed within the liver cells from the fusion of apoB-
100 with a triglyceride-rich lipid droplet, followed by addition of apoE, 
apoA-I and apoA-II. After its release into the circulation, VLDL acquires 
apoC and apoE from HDL-2 in exchange for apoA-I, apoA-II, and 
phospholipids. 
As similar to chylomicrons, this exchange with HDL-2 is essential 
for further metabolism of VLDL by LPL and the VLDL receptor. When 
circulaying through the capillaries perfusing the muscle and adipose 
tissues, VLDL particles attach to the endothelial surface via their apoE. 
This binding result in interaction of VLDL with LPL and the VLDL 
receptor. Following   this apoC-II content of VLDL activate LPL, which 
causes hydrolysis of VLDL. 
 
HDL 
The most important function of HDL is retrieval and transport of 
cholesterol from the extrahepatic tissues for disposal in the liver.(9). This 
process which is commonly called as reverse cholesterol transport. This is 
very much important for cellular cholesterol homeostasis as well as 
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protection against atherosclerosis, kidney disease, and other 
complications. Other than this, HDL plays a major role in metabolism of 
triglyceride-rich lipoproteins by acting as a donor and acceptor of apoC 
and apoE for the metabolism   chylomicrons and VLDL, a process which 
is essential in triglyceride metabolisam. Other funtions of HDL are, 
acting as potent endogenous inhibitor of inflammation, platelet adhesion, 
and LDL oxidation. 
 
 
 
 
 
 
 
 
 
 
SUMMARY OF LIPID METABOLISAM 
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PREGNANCY HYPERTENSION 
Hypertensive disorders of pregnancy tends to complicate nearly 
five percentage to ten percentage of total pregnant cases. 
Along with hemorrhage & infection, these disorders constitute one 
limb of the dangerous triad of maternal morbidity as well as mortality. 
With hypertension, the preeclampsia syndrome , as been proven to be the 
most deadly one. 
Elevated blood pressure seen in pregnancy which is otherwise 
known as gestational hypertension constitutes the non proteinuric 
increase in blood pressure. The study done by Berg & colleagues has 
suggested that nearly 50 percentage of the mortality that is occuring as a 
consequence of increased blood pressure could have been prevented. 
 
NEW TERMINOLOGY AND CLASSIFICATION 
1. Gestational hypertension—formerly called as pregnancy 
induced hypertension disorder 
2. Preeclampsia (PE) and eclampsia syndrome 
3. Preeclampsia syndrome superimposed on chronic 
hypertension 
4. Chronic hypertension. 
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Gestational Hypertension 
• Systolic Blood Pressure of140mmhg or diastolic Blood Pressure  of 
90 mm Hg , detected for the 1st time in  pregnancy 
• absence of excretion of protein in urine 
• Blood pressure falling back to reference level prior to twelve 
weeks post delivery 
• Only after the delivery, an ultimate diagnosis can be established. 
• Patient might develop other Characteristic features of 
preeclampsia, like, pain and sensation of discomfort in the region 
of epigastrium  or decrease in platelet count. 
 
Preeclampsia (PE) 
The following are the minimum criteria required for establishing a 
diagnosis.(4) 
• Blood Pressure level of 140/90 mmHg after twenty wks of 
conception 
• Twenty four hour urine protein excretion being 300mg or a 
dipstick assay giving the value of 1+. 
The diagnosis can be made with a high index of certainity if the 
following criterias are fulfilled 
• Blood pressure level of  160/110 mm Hg 
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• Twenty four hour urine protein excretion being 2gram or a dipstick 
assay giving the value of 2+. 
• The creatinine level in the blood being more than 1.2 mg/dL 
• Platelets count < 100,000/L 
•  Increased LDH  suggestive of Microangiopathic hemolysis 
• Increased values of liver enzymes such as elevated  SGOT  as well 
as SGPT 
•  Development of symptoms like headache or defects of vision. 
Continuous painful sensation in the region of epigastrium 
 
Eclampsia 
• A pregnant mother developing epilepsy which could not be 
explained by any other cause. 
 
Preeclampsia which is being superimposed on a state of chronically 
elevated blood pressure 
• Twenty four hour urine protein excretion being 300 mg which is of 
recent origin in a female who is a known case of hypertension 
without showing any excretion of protein in her urine prior to 
twenty wks of her pregnancy. 
Rapid elevation in the quantity of protein which is being excreted 
in the urine or a rapid increase in BP or thrombocytopenia with a value of 
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platelet < 1 Lakh/dl developing in a female who has history of elevated 
BP & protein excretion in urine even prior to twenty wks of pregnancy. 
 
Chronic Hypertension 
• Females with a blood pressure in the range of 140/90mmHg which 
is being diagnosed either prior to conception or prior to twenty wks 
of conception and which could not be attributed to the 
trophoblastic disoders occuring in pregnancy.  
or 
• An elevated blood pressure which is being diagnosed for the first 
time after a period of twenty wks of gestation & the elevation 
being continuously present even after twelve wks of delivery. 
 
RISK FACTORS 
1. Young and nulliparous women 
RECENT STUDIES - Sibai and Cunningham (2009),(4) found that 
the incidence of PE in nulliparous ranges from 3 to 10 percent, it is less 
than that for nulliparas. however, Ananth and Basso (2009) reported that 
the stillbirths were more commonly seen with in hypertensive multipara. 
2. Obesity 
3. Multifetal gestation, 
4. Maternal age older than 35 years, 
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5. African-American ethnicity 
6. Maternal obesity Body mass index (BMI) 
Risk of PE increases from 4.3 % for women having a body mass 
index  < 20 kilogram per metre square to 13.3 % in women having a BMI 
> 35 kilogram per metre square  (Sibai and co-workers, 2000). 
Follwing factors are associated with reduced risk of PE as shown by 
various studies  
Smoking (Bainbridge and associates, 2005) 
Placenta previa (Ananth and colleagues, 1997). 
Normotensive during her first pregnancy (Getahun and colleagues 
2007). 
  
PATHOPHYSIOLOGY 
The pathophysiology behind preeclampsia is unknown. Several 
theories have been postulated , but none of the theory point towards a 
single etiology. Understanding of the same can greatly influence the 
management and outcome.  
 
Placental factor 
The current concept is that the placenta plays an important role. 
Most of the recent studies support the theory of incomplete trophoblastic 
invasion of uterine spiral arteries, leading to reduced perfusion of 
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placenta, which causes production of antiangiogenic factors causing 
endothelial dysfunction. This abnormality of endothelium leads to the 
elevation in blood pressure, altered permeability of vasculature system 
well as the stimulation of coagulation pathway. It also cause damage to 
filtering mechanism in the kidney leading to proteinuria. This circulating 
angiogenic factors are demonstrated in serum of preeclapsic patients even 
before the disorder has shown manifestations clinically. Eventhough the 
above mentioned pathogenitic mechanism is very much appealing, it is 
not accepted by the foundation for pre-eclampsia. This was according to 
the study done by Ness et al in the year 2003. 
Thioredoxin and glutaredoxin are considered to be the reducing 
systems in placenta. One of the recent studies had analysed this system 
present in the placenta of women with preeclampsia. In this study, they 
have analysed the tissues from placenta of normal pregnant ladies and 
also in females with mild to severe preeclampsia. The samples have been 
collected as early as possible after the delivery. And it was found that the 
above mentioned proteins have been elevated nearly 3-4 times in the 
placenta of preeclampsia women in comparison with that of placenta 
from normal gestation. This indicates that the placentas of preeclampsia 
women have been continuously under oxidative stress. It also shows the 
adaptive induction of thiol/disulphide oxidoreductases in cases of 
 16
preeclampsia.This was proven in the study done by   Pankaj in the year 
2008. . 
 
Other related observations pointing placental factor as the cause of 
preeclampsia. 
1 The studies done by Fisher et. al in the year 1999, study of 
August et.al in the year 1995 as well as that done by  Hanretty et al in the 
year 1988. 
Observe that placental hypoxia as the cause for pathogenesis of 
preeclampsia. 
In the early stage of gestation, spiral arteries present in the uterine 
musculature will be invaded by the tissues of cytotrophoblast. This will 
result in the replacement of endothelial lining present in those 
vasculature. By end of second trimester there wont be any endothelial 
lining for spiral arteries and it is replaced by cytotrophoblast. 
This change of the spiral vessels present in the uterine musculature 
leads to decrease in resistance offered by arterioles. This is accompanied 
by an enhanced blood flow to the foetus. The cytotrophoblast, in cases of 
preeclampsia, will be invading only up to proximal portion of decidua 
and nearly 40%-50% of spiral vessels present in the placental system will 
escape from the trophoblast induced remodelling of vascular system. This 
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is from the study done by Roberts et al in the year 1991 and Brosens et al 
in the year 1972. 
Other important observation for the significant prominence played 
by placenta as a causative factor of preeclampsia is the sudden 
improvement & recovery of the condition after the delivery has taken 
place. 
 
Immunological Factor 
CD3 Zeta Protein 
Pre-eclampsia is featured by reduced inhibition  of expression of 
CD3-zeta protein ,leading to altered functionig of  T-cells when a 
comparison has been made with normotensive pregnancies. CD3-zeta has 
been found iside the membranous area of the receptor for T cells which is 
neede for the multiplcation of T cells. 
T cell mediated immunity is suppressed in normal pregnancy. 
Normal gestation has been shown to have low expression of CD3-zeta 
protein which is required to suppress cell mediated immunity inorder to 
save the fetus from rejection of allograft. 
All these studies observe that there may be some factors that down 
regulate CD3-zeta, and pre eclampsic patients are lacking this, leading to 
increased inflammatory response. 
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Sleeping Disorders Breathing in Pre-eclampsia 
 Sleep-disordered breathing is divided in to snoring, upper airway 
resistance disorder & also in to obstructive sleep apnea-hypopnea 
disorder. These constitute snoring at one end and OSA at the other end. 
These are associated with oxygen desaturation or sleep fragmentation. 
Estrogen causes hyperemia and nasopharyngeal edema which can lead to 
upper airway obstruction. This is from the study of Young et al in the 
year 2001. According to the work done by Young et al. in the year 1997 it 
has been observed that this sleep disordered breathing is more common in 
patients with preeclampsia. 
 
Significance of the renin-angiotensin mechanism in the 
pathophysiology of pre-eclampsia AbdAlla et al., (2001), Nielsen et al., 
(2000). 
Pre-eclampsia has been considered as a disorder with elevated 
blood pressure that has been proven to be unique in having persistent 
involvement of the renal system. Renin-angiotensin system (RAS) is the 
system which is postulated in the etiopathogenesis involved in 
preeclampsia. This model has made the observation that a RAS which is 
tissue-based has been found in uteroplacental system. Stimulation of 
uteroplacental tissue RAS leads to the entry of angiotensin II in to 
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systemic vasculature and this might contribute to the mechanism involved 
in pre-eclampsia. 
 
Other observation with RAS 
1 Various components of this system including renin, angiotensinogen 
I& II, as well as aldosterone have been elevated in normal pregnancy 
Skinner (1972) 
• increased adrenal sensitivity to ANG II Symonds et al., (1972) in p 
preeclampsia 
• incresed level of ANG II  for a given level of renin in 
preeclampsia 
• Association of preeclampsia with enhanced sensitivity to 
angiotensinogen II Gant et al., (1973) 
Role of Adenosine Receptor Expression. [Hasko and Cronstein 
2004],  Ajamieh et al.,(2008) 
Adenosine is derived from the metabolism of adenine nucleotides. 
It has been secreted in various cells including placental tissue, as a 
reactive mechanism to decreased oxygen supply, decreased blood supply 
& also to inflammation. It function as a regulator of vascular resistance, 
angiogenesis, inflammation & oxidation induced stress. This is based on 
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the study done by Ajamieh et al in the year 2008.Particular receptors of 
adenosine are present which mediates the various physiological effects. 
According to the studies done by Yoneyama et al in the year 2002., 
it has been shown that  the concentration & upregulation of adenosine 
receptor tends to be  substantially increased in placenta of   females with 
preeclampsia 
 
FUNCTION OF VASCULAR ENDOTHELIUM [Taylor et al, 
(1999) and Roberts's et al, (1989)] 
Taylor et al in the year 1999 & Roberts's et al in the year 1989. 
have studied about the vascular endothelial functions. 
The functions of vascular endothelium include 
• the regulation of tone of smooth muscle 
• secretion of various factors that could result in  constriction as well 
as dilatation of blood vessels 
• through secreting various soluble agents it regulates not only 
anticoagulation & antiplatelet function, but also fibrinolysis. 
Placental secretion of these substances as a result of decreased 
blood supply will cause abnormalities in functions of endothelium. 
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The observation that the defect in the function of endothelium as 
initial mechanism of preeclampsia, suggests this as a probable cause for 
pathogenesis of PE. 
 
ENDOTHELIAL DYSFUNCTION 
Markers of endothelial dysfunction 
Plasma thrombomodulin. 
Von Willebrand factor 
Fibronectin 
TNF alpha 
IL-1 levels 
 IL-2 
Preeclampsia is a disorder of cells of endothelium. Several 
indicators of abnormalities of functions of endothelium have been found 
elevated in serum of patients with preeclampsia. This has been shown in 
the studies done by Taylor et al in the year 1999 & Roberts et. al in the 
year 1989.All these markers were studied in preeclampsic patients by 
various investigators .the majorities of these studies reported a significant 
association with this biomarkers. Sunder et al., (1989) Vince et al., (1995). 
Elevated assay of platelet endothelial adhesion molecule-1 is 
shown to be associated with PE. This has been observed in the works of 
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Taylor et al & Roberts's et al. From these studies it appear that platelets 
play an important role in the pathogenesis of pre-eclampsia. 
One among the other vascular adhesion molecules that are found 
elevated in preeclampsia is vascular adhesion molecule-1. In addition to 
this intercellular adhesion molecule-1 is elevated along with an elevation 
in E-selectin level. 
Risk Factors of Developing Preeclampsia Adelusi et al., (1986), 
Steegers et al., (1998)., Visser et al. (1999). Magnussen et al. (2007) 
Females with an incidence of pre-eclampsia in their previous 
gestations have an increased rate of developing the disease in the 
subsequent pregnancies. This is shown in the study of  Adelusi et al in the 
year 1986.According to study done by Steegers in 1998,there is an 
incresed risk with advancing age of gestation. Based on the severity of 
protein excretion in urine, the risk of developing preeclampsia in 
subsequent gestations could be assessed. 
Degree of protenuria in their previous pregnacy was studied by 
Visser et al. (1999) and has got leanier relationship with development of 
pre-eclampsia in future pregnancies. 
 Blood pressure in previous pregnancy tends to show a positive 
relation with development of preeclampsia. This has been suggested in 
the work of Magnussen et al in 2007. 
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Female sex hormone 
As per the study done by Patrizia et al in 1999, these hormones 
have a profound influence on serum lipid profile. Towards later part of 
gestation, estrogen lowers the secretion of VLDLs and inhibit lipolytic 
activity taking place in mother. This is based on the study of  Karl et al in 
2003.This is a protective mechanisam so that more triglycerides will be 
shunted towads  fetoplacental system inorder to cope up with the 
increased demand of fetus for the nutrition. The role of estrogen in 
increasing density VLDL formation & lowering the action of liver lipase 
has a significant value in pathogenesis involved in PE. (Based on the 
study of Alvarez et. al, in the year 1996).  
 
FUNCTIONS OF ESTROGEN 
1. Enhances the dilation of blood vessels 
2. Suppress the reaction of vascular system to injury process. 
3. Prevent the occurence of atherosclerosis. 
4. Increases the bioavailability of endothelial-derived nitric 
oxide. 
Alterd Estrogen-induced vasodilatation can be an important 
pathogenetic mechaniasm for the development of PE. Register et al., 
(1998). 
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Nitric Oxide and pre-eclampsia 
Significant data shows that Nitric oxide (NO) formation is 
increased in normal gestation. (Based on the study by  Sladek et al in 
1997).  Increase in synthesis of NO acts as a key factor in the dilatation of 
vessels in the pregnant kidney. (according to the study by Sladek et al in 
1997). NO function as a significant factor regulating vasodilation during 
normal gestation, so decreased NO production of preeclampsia may play 
a role in the disease process.  
 
Homocysteine in preeclampsia 
Homocysteine which is one of the essential amino acid is needed 
for  normal growth of our cells. Its elevated levels in maternal serumhas 
been related to various disorders mediated by placenta like PE. (Based on 
the study of Mignini et al. in 2005). Its quantity has been considerably 
elevated once preeclampsia is established. (Ingec et al., 2005).Due to 
inadequacy of consistent records, this relationship that has been noticed 
could not be regarded as a causative factor according to present literature. 
BMI & Preeclampsia [Sahu el al., (2007), Bhattacharya et al 
(2007), Leeners et al., (2006), Ramos et al., (2005), Kabiru et al., (2004).] 
Females who have been grouped as obese according to BMI values in the 
1st 3months of gestation have been found to develop lowered 
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endothelium-dependent and independent dilation of vessels when 
comparison was drawn with lean women. (based on the study by Stewart 
et al., in 2007). Another study done by Ramsay et al in the year 2002, 
suggested that higher BMI in initial part of gestations has been related 
with elevated systolic BP, triacylglycerol level and bring down level of 
HDL. 
Higher BMI in the initial phase of gestation tends to show frequent 
correlation with risk parameters of eclampsia (based on study by Sahu et 
al. in year 2007 & Bhattacharya et al in the year 2007. 
 
Diet & Nutrition in Preeclampsia 
The association between pre-eclampsia and inadequacy in nutrition 
both prior to conception as well as during conception had been observed 
in  several studies. One such example was the suggestion of including 
calcium mineral & fish oil in the diet of pregnant mothers. This was 
based on the analysis from several studies which showed a relationship 
between food intake & prevalence of pre-eclampsia among several 
groups. 
Studies done by Mahomed and Atallah et al showed that by adding 
zinc & magnesium in the diet have been helpful in maintaining the 
general physiological mechanism of pregnancy period. These studies 
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were carried out in the year 2008 and 2004 respectively. Research work 
done by Makrides, which was carried out in the year 2008, showed that 
introduction of various antioxidants including vitamin C & E, selenium & 
garlic in the diet can compensate for the oxidative stress .Study also 
stressed the role of folic acid in bringing down the elevated serum 
homocysteine values. 
Several nutritional parameters have also been related to pre-
eclampsia condition. Various studies have been done among the Mayan 
Indians in Guatemala, who showed the habit of soaking corn inside lime 
prior to cooking process. Because of this habit of the people in those 
regions, their diet was rich in calcium and the rate of pre-eclampsia as 
well as eclampsia was  minimal among them.  Based on this observation 
,it was suggested that by enhancing the calcium content of pregnant diet it 
could be possible to achieve  a reduction in the prevalence of pre-
eclampsia in the females having less calcium . 
The study done by Dyerber et al among the Greenland Inuits 
population  who consume plenty of oily fishes showed that the prevalence 
of pre eclampsia in those subsets was minimal. This observation further 
emphasized the role of fish oil in the prevention of eclampsia. 
According to this study, not only fish oil, but also minerals like 
magnesium, zinc, selenium & several vitamins that are proven to have 
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antioxidants properties like vitamin C & E as well as folic acid have a 
significant role in decreasing the incidence of pre eclampsia. 
Adequate nutrition is essential for the normal growth of foetus. 
Hence, dietary factors play a prominent role in the health of pregnant 
females. 
Studies done by Krammer which was in the year 2000 and 
Laurence et al in the year 1980 showed that inadequate nutrition among 
pregnant mothers had resulted not only in abortion and decreased growth, 
but also in learning  defects & personality disorders in the children. 
In this scenario, the role of antenatal health workers is very 
significant. They should be educated and trained properly so that they 
will provide iron, calcium & vitamin tablets to the pregnant mothers.It is 
very essential to have a good idea about the diet & nutrition of pregnant 
female. This will help in the implementation of nutrition and education 
programs effectively. 
Studies done by  Picciano (which was in the year 1996)  had shown 
that there is an enhanced reqirement of energy as well as nutrients in the 
pregnant period, which inturn is dependent on the built and nourishment 
of those ladies. The need for extra energy is low for females with good 
nourishment as their body have a better adaptive mechanism. Show only 
a minimal 
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An average sized Indian female, in her final three months of 
antenatal period, should take 2000 kilo calories per day on an average. 
However, many ladies in developing nations reduce their food 
consumption in pregnancy inorder to get a small baby. This is based on 
their belief that as the size of the baby decreases, obstetric complications 
become lesser. This was found in the study done by Brems et al in the 
year 1988. 
But the current datas prove that new borns with small birth size 
tends to show more medical problems in future life. This was stressed in 
the study done by Godfrey and Barker. 
The greatest essential principle that needed to be followed by a 
pregnant mother is to take a diet which is balanced as well as healthy. 
Such a diet consists of food material from various categories in adequate 
quantity inorder to ascertain correct nutrition. She requires all essential 
nutrients in adequate proportion. 
The role of nutrition in organ development, growth and 
reproductive process is very importantl. It also play a vital role in 
enhancing the body’s immune status   as well as in the prevention of 
various disease processes. 
Pregnancy, though a normal physiological process, is perhaps a 
stressful situation to the human body. Hence, this is a condition which 
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demands enhanced intake of nutrients so that body’s extra requirements 
are fulfilled. This was well pointed out in the study done by Amy, in the 
year 1995. 
According to the study done in Harvard, prevention of pre-
eclampsia was possible by consuming  a minimum of seventy five grams 
of protein daily. When a female becomes pregnant, her blood volume gets 
elevated by nearly two fold .Hence a corresponding increase in  her 
nutrient intake to meet the body’s requirement  is absolutely essential.  
 
Management of Pre-eclampsia 
Pevention of pre-eclampsia is infact a real challenge. The steps and 
measures taken for its prevention purpose have not been successful. 
(Sibai 1998). 
A meta analysis of fourteen trials which was done by giving low 
dosage of aspirin (a dose of 60-150mg per day) in mothers with risk 
parameters for preeclampsia showed that the incidence of preeclampsia as 
well as perinatal mortality has been decreased with the usage of drug 
aspirin. But it has failed to show any impact on birth weight or any 
reduction in the rate of abruption. (based on the study done by 
Coomarasamy et al in the year 2003). There was only a minor reduction 
in the occurrence rate when aspirin in low dosage was given to unselected 
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nulliparous females. (From the study of Sibai & Caritis in the year 
1993).But it is justifiable to administer low dosage aspirin to high risk 
mothers ,starting from the 12th week of pregnancy. The safety profile of 
using aspirin in small dosage in 2nd & 3rd trimesters has been clearly 
proven. 
 
Antihypertensive Medications 
The sudden rise in blood pressure can result in catastrophic 
cerebrovascular & cardiovascular events. These constitute the important 
reasons of mortality & morbidity among pregnant mothers. Hence, the 
timely  and proper management of elevated blood pressure in pregnancy 
plays a  significant role. 
The antihypertensive therapy has been proved effective in the 
prevention the above mentioned adverse events. However, in mild 
preeclampsia it has not proven to be effective. This was observed in the 
study done by Bolte et al, that was done in 2001.  
The latest evidences from Cochrane review showed that the role of 
blood pressure lowering medications in mild to moderate elevation of 
blood pressure in pregnant period is uncertain. 
This was further stressed by the meta analysis done in blood 
pressure lowering medications in pregnancy. It had shown that the usage 
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of these medications in females with mild form of disease enhanced the 
possibility of having a small sized baby. 
It has been adviced by few people that BP lowering drugs could be 
used if there is a persistent elevation of systolic blood pressure of 
minimum 160mmHg & diastolic level of minimum 110mmHg. 
Intravenous hydralazine, labetalol & nifidipine which is of short 
duration of action taken orally have been the frequently used  drugs for 
the treatment of sudden rise in blood pressure in pre-eclampsia females. 
Among the above, hydralazine given through IV route has been regarded 
as the medication of choice by various people. 
A meta analysis of twenty one studies was done by Magee & his 
colleagues  & it was done in 893 females .Of that 8studies were on the 
comparison between hydralazine  and nifedipine  & 5 studies were on the 
comparison of hydralazine & labetalol. The work found that drug 
hydralazine has been related with substantially greater adverse effects in 
mothers & had a very poor maternal as well as perinatal outcome when 
comparison was made with other two drugs. Analysis had also found the 
essentiality of properly monitored clinical trials for the comparison of 
labetalol & nifidipine in the therapy of severely elevated blood pressure 
among preeclampsia females. Infact among the various medications used 
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for lowering the blood pressure, it has not been finalised to consider 
which  single medication as the drug of choice. 
In the subgroup analysis which was carried out, it was suggested 
that the efficiency of beta blockers might be low when a comparison was 
made with blockers of calcium channel. This work was carried out by 
Papatsonis et al  & also by and Tsatsaris et al in the year 2001. 
 
Pattern of  lifestyle 
It was suggested that rest as well as exercise could influence blood 
pressure level. The role of variations of activity pattern of females when 
they become pregnant  in the incidence of preeclampsia is not yet certain 
2small trials  that have been carried out among the high risk females with 
normal blood pressure, have shown that those who were taking rest for a 
duration of minimum  4hours during day time had decreased incidence of 
preeclampsia. However, among the hospitalised hypertensive females the 
role of rest is not very certain. Also it is not clear whether the habit of 
taking rest had any extra benefit over routine activity pattern. 
Few studies were of the opinion that the increased level of exercise 
has the potential to  bring down the incidence of preeclampsia. But none 
of these datas were proven to be statistically significant. Hence, the 
decision to take rest or to do more exercise should be based on the 
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particular individual’s personal opinion. This was the suggestion from the 
study of Lelia et al in the year 2006. 
 
Recurrence  
The incidence of preeclampsia  among females who had history of 
the same in their  prior pregnancy was found to be nearly 10 percentage 
according to the study done by Chesley in the year 1978.Based on 
studies  of several research workers, females with history of severe 
preeclampsia & eclampsia carried a 20perceentage risk of having   the 
same in her next pregnancy.. 
 
Seizure Prophylaxis  
The medication of choice for the prevention of epilepsy among 
preeclampsia mothers is magnesium sulphate. The exact mechanism by 
which magnesium sulphate prevents epilepsy is not clear. However, 
various randomised trials  had made the observation that  the above drug 
has extra benefits over other drugs like benzodiazepam, phenytoin  in the 
prophylaxis of early eclamptic fits as well as recurring epilepsy. Study 
done by Sibai in the year 2004 also strengthened the above finding. 
The treatment has to be initiated at the time of onset of labor or 
before the cesarian & it has to be given for next one day after the 
delivery. 
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 According to the severity of the underlying disease, the decision to 
prolong the use of medication after delivery can be formulated. Therapy 
is initiated with a loading bolus of parentral magnesium sulphate, which 
is generally four to six grams & it is followed by maintenance dose which 
is usually one to three gram per hour. 
Magnesium sulphate act by inhibiting calcium transport as well as 
the aggregation of platelets & also by dilating the cerebral vasculature. 
These are the mechanisms that has been suggested for the antiepileptic 
action of the drug. (According to the study done by Sibai in the year 
2004). 
But those individuals who are treated with the above medication 
requires intensive monitoring to identify the features of magnesium 
induced toxicity very early itself. Various manifestations of toxicity 
include absence of knee jerk, respiratory difficulty as well as decreased 
urine output. This emphazise the need of examining knee jerk atleast 
fourth hourly. Rate of respiration as well as saturation should also be kept 
under close observation. There should be urine output of minimum thirty 
millilitre per hour. 
Serum magnesium value has to be found out if there is a doubt of 
toxicity 
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Majority of the obstetricians, prefer to keep the value less than 
9mg/dl.But the features of toxicity has been noted even at a value less 
than 6mg/dl.Hence, irrespective of the serum level close monitoring of 
the individual has to be effectively carried out. This has been pointed out 
by Sibai in the year 2004. 
Every female who is in labour with features of severe 
preeclampsia, has to be treated with magnesiumsulfate inorder to prevent 
epilepsy. But there is a controversy regarding the role of magnesium in 
the prevention of seizures in cases of mild preeclampsia. Though ACOG 
has adviced to use magnesium in severe cases of preeclampsia,it has not 
advocated the use of above drug in mild forms of preeclampsia.Certain 
obstetricians avoid the use of magnesium if the blood pressure has been 
controlled &/or only increased to a small extend & if the count of 
platelets is within the normal limits. However, some practioners suggest 
magnesium therapy even to those with PIH as a minor proportion of these 
women show a tendency to progress to preeclampsia. Study done by Sibai 
in the year 2004 showed that it is essential to give magnesium to 
approximately 100 women with PIH  inorder to avoid one eclampsia case. 
 
Plasma volume expansion 
Certain females with severe form of preeclampsia tend to have 
elevated haematocrit & decreased plasma volume. Based on this 
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observation, the use of colloids or crystalloids for the expansion of 
plasma volume has been advocated inorder to enhance the maternal as 
well as uteroplacental blood flow. But the condition of volume overload 
has to be avoided as it can result in life threatening pulmonary or cerebral 
oedema. Moreover, higher rate of volume expansion should be done with 
the monitoring of central venous pressure which is an invasive method & 
these procedures  by itself  have a significant risk. This has been shown in 
the studies of Bolte et al in the year 2001 . 
  
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
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MATERIALS AND METHODS 
 
Materials  
Source of Data 
This study was conducted at Mahatma Gandhi Memorial 
Government Hospital, Trichy, Tamilnadu in colloboration with 
department of obstetrics and gynaecology during the period of january 
2011 to august 2012. 
 
Study Design 
Single centre, cross-sectional and analytical study. 
 
Period of Study 
The work was carried out from january2011 to august, 2012. 
 
Ethical Committee Approval 
Ethical committee approval obtained from the Institutional Ethical 
committee. 
 
Inclusion criteria 
Study were conducted on 90 women ranging in age from 20 to 30 
years. They were grouped in to three. All the pregnant participents were 
in their 3 rd trimester with single intrauterine pregnanacy. 
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GROUP A-preeclampsic women -after 20 wks of pregnancy with 
Blood Pressure ≥ 140/90 and proteinuria (positive dipstick). 
GROUP B-normotensive pregnant women-individuals with Blood 
Pressure ≤120/80 for control. 
GROUP C-normotensive non pregnant women- relatives of some 
patients and some staff workers  of labour ward willingly consented to 
take part  in this study. 
All the participants were inquired by a questionnaire containing 
their personal history, family history of PIH, Twins, Hypertension and 
Diabetes, Drug history and their symptoms. 
 
Exclusion criteria 
Women with past history of diabetes mellitus, hypertension, kidney 
diseases, hepatic dysfunction and dyslipidemia were excluded from the 
study. 
 
Consent 
An informed consent was obtained from all the participants. 
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Methods of collection of data 
Blood sample collection 
Neraly 8ml of blood was collected in the fasting state & the below 
mentioned factors have been analysed in cases as well as in controls. 
Blood lipid parameters were estimated with the help of autoanalyser 
based on enzymtic colorimetric process. This include not only 
triglyceride (TG) & total value of cholesterol (TC), but also the value of 
HDLcholesterol (HDL-C). As per Friedewald’s formula serum values of 
LDL & VLDL were found out. That is LDL Cholesterol = Total 
cholesterol - (triglyceide/5+ the value of HDL cholesterol) (TG/5 + HDL-
C) The value of  VLDL is Triglyceride/5 
  
Blood pressure recording 
BP was recorded in sitting position with shygmomanometer. BP 
was recorded after the subject had a rest of minimum ten minutes.Based 
on korotkoff sounds BP was recorded. BP at which the sounds started to 
appear had been taken as systolic value of BP and that when sound 
disappears had been taken as diastolic pressure. The size of the BP cuff 
used  was 12x22cm . 
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Calculation of body mass index 
Anthropometric measurements 
Height was recorded with  tape to the nearest one centimeter. 
Subjects were instructed to stand upright without shoes with their 
back against the wall, foot together and eyes directed forward. 
Weight was measured with weighing machine using spring balance 
that was kept on firm horizontal surface. The scale was checked on daily 
basis and calibration was done with known weights. Weight was recorded 
to the nearest 0.5 kg. 
 
The formula given below has been used to calculate BMI  
BMI=Weight (Height In Meters)2 
 
URINE ANALYSIS 
Midstream urine of the subjects that has been collected in the early 
morning has been analysed. Females were informed about the method to 
collect urine in the specified bottles. With the help of dipstick method 
analysis of collected urine was carried out. 
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Analysis of data 
The information collected regarding all the cases were tabulated 
in a master chart. Data was analysed with help of statistical soft ware 
tool epidemiological information package (EPI 2002). Using this 
software range, frequencies, percentages, means standard deviations, 
and p values were calculated. For comparison of multiple groups 
ANOVA test was used. Scheffe Post Hoc Test was used to find out the 
p value between the means. Pearson Correlation coefficients were used 
to find out the correlation between the variables. 
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 42
RESULTS 
 
Table 1 A 
Age distribution among the groups 
 
Group A Group B Group C 
Age 
N % N % N % 
20-22 9 30.0 7 23.3 2 6.7 
23-25 7 23.3 12 40.0 18 60.0 
26-28 9 30.0 8 26.7 9 30.0 
29-30 5 16.7 3 10.0 1 3.3 
Total 30 100.0 30 100.0 30 100.0 
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Table 1B 
 
 
 
 
BAR  DIAGRAM SHOWING THE DISTRIBUTION OF AGE 
AMONG THE GROUPS. 
 
Result –age is distributed among the groups, hence they are comparable. 
 
 
Age in years 
 
 Group A Group B Group C 
Minimum 21 20 22 
First quartile 22.0 22.8 23.8 
Median 25.0 25.0 25.0 
Third quartile 27.0 27.0 26.0 
Maximum 30 30 30 
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BMI 
Table 2A 
Distribution BMI among the groups. 
Group A Group B Group C 
BMI 
N % N % N % 
Under 
weight 3 10.0 5 16.7 8 26.7 
Normal 20 66.7 17 56.7 19 63.3 
Over weight 5 16.7 2 6.7 2 6.7 
Obsese 2 6.7 6 20.0 1 3.3 
Total 30 100.0 30 100.0 30 100.0 
 
 
 
BAR  DIAGRAM SHOWING THE DISTRIBUTION OF BMI AMONG 
THE GROUPS 
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Box plot diagram describing BMI:- Lower and upper end of the 
whisker represents minimum and maximum BMI respectively. Lower 
border of the rectangular box represents the 25th percentile, upper border 
represents 75th percentile and the line of separation (middle line) of the 
two coloured box represents the median BMI. 
Table distribution among the groups. 
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Comparison of BMI 
 
N Mean sd F p 
Group A 30 23.49 4.49 
Group B 30 23.91 5.98 
Group C 30 22.20 4.19 
.970 
 
 
.383 
 
 
Total 90 23.20 4.95   
 
 
Table 
Post hoc test Multiple comparison p 
BMI Group A Group B .748 
  
Group A Group C .314 
  
Group B Group C .185 
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RESULT 
There is no significant difference in BMI among the groups, hence 
they are comparable. 
 
TOTAL CHOLESTEROL 
Table3A 
Comparison of Total cholesterol in (mg/dl) 
Normal Value: <200mg/dl 
 
N Mean sd F p 
Group A 30 172.5 12.1 
Group B 30 192.2 11.2 
Group C 30 165.2 13.4 
39.032 <0.001 
Total 90 176.6 16.7   
 
 
Box plot diagram describing distribution of Total cholesterol 
 
 
 
 48
 
 
  
Post hoc 
test 
Multiple 
comparison P value 
T.CHOL Group A Group B <0.001 
 
Group A Group C .024 
 
Group B Group C <0.001 
 
 
Result –group B showed high level of total cholesterol. P value is 
significant between A and B, and B and C.P value is not significant 
between group A and C. 
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TRIGLYCERIDE 
Table 4A 
Distribution of TGL among the groups. 
Normal value <150mg/dl. 
in mg/dl 
 
 Group A Group B Group C 
Minimum 169.0 100.0 100.0 
First quartile 195.0 106.0 102.8 
Median 204.5 110.0 109.0 
Third quartile 252.5 118.5 122.3 
Maximum 290.0 166.0 146.0 
 
 
Box plot diagram describing distribution of Triglyceride 
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Table 4B 
Comparison of Triglyceride in (mg/dl) 
 
N Mean sd F p 
Group A 30 222.0 36.6 
Group B 30 113.8 12.1 
Group C 30 113.7 13.1 
212.476 <0.001 
Total 90 149.8 56.3   
 
 
Post hoc test Multiple comparison p 
Group A Group B <0.001 
Group A Group C <0.001 Triglyceride 
Group B Group C 0.983 
 
Result - P value is significant between A and B ,and A and C.P 
value is not significant between group B and C. 
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HDL 
Table5A 
Distribution of HDL among the groups. 
Normal value - >40 mg/dl 
 
N Mean sd F p 
Group A 30 41.9 4.3 
Group B 30 46.9 3.0 
Group C 30 50.9 4.9 
35.993 <0.001 
Total 90 46.6 5.5   
 
 
Box plot diagram describing distribution of HDL 
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Table5 B 
Comparison of HDL in (mg/dl) 
Post hoc test Multiple comparison p 
Group A Group B <0.001 
Group A Group C <0.001 HDL 
Group B Group C 0.120 
 
Result - P value is significant between A &B ,and A & C . 
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LDL 
Table 6A 
Distribution LDL among the groups. 
Normal Value <130 mg/dl. 
 
 
N Mean sd F p 
Group A 30 81.1 8.8 
Group B 30 127.6 11.4 
Group C 30 91.5 14.9 
124.292 <0.001 
Total 90 100.1 23.2   
 
 
Box plot diagram describing  LDL 
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Table 6B 
Comparison of LDL in (mg/dl) 
Post hoc test Multiple comparison p 
Group A Group B <0.001 
Group A Group C .001 LDL 
Group B Group C <0.001 
 
Result - P value is significant between A & B  and B & C.P value 
is not significant between group A and C. 
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VLDL 
Table7A 
Distribution of  VLDL  among the groups. 
Normal value 10 – 30mg/dl. 
 
 
N Mean sd F p 
Group A 30 44.4 7.3 
Group B 30 22.8 2.4 
Group C 30 22.7 2.6 
212.476 <0.001 
Total 90 30.0 11.3   
 
 
Box plot diagram describing distribution of  VLDL 
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Table 7B 
Comparison of VLDL in (mg/dl) 
Post hoc test Multiple comparison p 
Group A Group B <0.001 
Group A Group C <0.001 VLDL 
Group B Group C .983 
 
 
Result - P value is significant between A & B  and A & C.P value 
is not significant between group B and C. 
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BLOOD UREA 
Table8A 
Distribution of blood urea level among the groups. 
 
 
N Mean sd F p 
Group A 30 24.7 5.7 
Group B 30 21.8 3.4 
Group C 30 21.5 3.1 
5.113 .008 
Total 90 22.7 4.4   
 
Box plot diagram describing blood urea level among the groups 
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Table 8B 
Comparison of Blood urea in (mg/dl) 
 
Post hoc test Multiple comparison p 
Group A Group B .010 
Group A Group C .005 Blood urea 
Group B Group C .784 
 
Result –p value is not significant. 
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SERUM CREATININE 
Table9A 
Distribution of  Serum Creatinine  among the groups. 
 
N Mean sd F p 
Group A 30 .81 .21 
Group B 30 .81 .16 
Group C 30 .73 .16 
1.974 .145 
Total 90 .79 .18   
 
Box plot diagram describing  distribution of  Serum Creatinine  . 
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Table 9B 
Comparison of S. Creatinine in (mg/dl) 
 
Post hoc test  Multiple comparison p 
Group A Group B .942 
Group A Group C .083 S. Creatinine 
Group B Group C .096 
 
Result –p value is not significant. 
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RISK RATIOS 
TG / HDL 
Table 10 A 
Distribution TG / HDL  among the groups 
 
N Mean sd F p 
Group A 30 4.74 .69 
Group B 30 2.73 .35 
Group C 30 2.26 .37 
209.201 <0.001 
Total 90 3.24 1.19   
 
 
Box plot diagram describing 
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Table 10B 
Comparison of TG/HDL 
 
Post hoc test Multiple comparison p 
Group A Group B <0.001 
Group A Group C <0.001 TG/HDL 
Group B Group C <0.001 
 
LDL / HDL  
Table11 A 
Distribution of LDL / HDL among the groups. 
 
N Mean sd F p 
Group A 30 1.75 .29 
Group B 30 3.06 .36 
Group C 30 1.83 .41 
127.004 <0.001 
Total 90 2.21 .70   
 
 
Box plot diagram describing  LDL/HDL 
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Table 11 B 
Comparison of LDL/HDL 
 
Post hoc test Multiple 
comparison p 
Group A Group B <0.001 
Group A Group C .411 LDL/HDL 
Group B Group C <0.001 
 
Result –p value is significant between group A &B, and group 
B&C. 
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HDL / VLDL 
Table12A 
Distribution of HDL / VLDL among the groups. 
 
N Mean sd F p 
Group A 30 1.08 .15 
Group B 30 1.86 .23 
Group C 30 2.27 .36 
162.418 <0.001 
Total 90 1.74 .56   
 
 
Box plot diagram describing 
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Table 12B 
Comparison of HDL/VLDL 
 
Post hoc test Multiple comparison p 
Group A Group B <0.001 
Group A Group C <0.001 HDL/VLDL 
Group B Group C <0.001 
  
Result – p value is very significant among the groups. 
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TC/HDL 
Table 13A 
Distribution of TC/HDL among the groups. 
 
 
N Mean sd F p 
Group A 30 3.70 .35 
Group B 30 4.61 .39 
Group C 30 3.28 .46 
86.958 <0.001 
Total 90 3.86 .68   
 
Box plot diagram describing TC/HDL. 
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Table 13B 
Comparison of TC/HDL 
 
Post hoc test Multiple comparison p 
Group A Group B <0.001 
Group A Group C <0.001 TC/HDL 
Group B Group C <0.001 
 
Result p value is significant. 
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Correlation between Triglyceride and  blood  pressure 
 
Table 14 
 
Correlation between 
Triglyceride SYS.BP DIA.BP 
Pearson Correlation 0.822** 0.865** 
p .000 .000 
N 90 90 
 
 
Result – There is highly significant positive correlation between 
TGL level with systolic and diastolic BP. 
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DISCUSSION 
 
This study was conducted to determine the lipid profile changes in 
Preeclampsia and to compare this with normotensive pregnant and non 
pregnant women. The study population was 90 patients with 30 patients 
in each group. All the women involved in the study were between 20-30 
years. It was ensured that none of the control group had diabetes mellitus, 
hypertension, dyslipidemia, renal, liver or any metabolic disorder. It was 
also ensured that none of the patients in the study group had any other 
medical disease. Serum total cholesterol, HDL cholesterol, LDL 
cholesterol, Triglycerides, LDL / HDL, HDL / VLDL, TC/HDL TG / 
HDL ratio were measured using an autoanalyser, after a 12 hour fasting. 
The results were statistically analysed. 
 
Age distribution  
The mean age for all the three group were 25 yrs. There was no 
significant difference in distribution of age among the groups. 
 
Distribution of BMI among the groups 
Among PE women 20(66%) were normal weight, 3 [10%] were 
under weight, 5[16%] were overweight and 2[6%] were obese. 
Among normotensive pregnant women 17(56%) were normal 
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weight, 5[16%] were under weight, 2[6%]were overweight and 6[20%] 
were obese. 
Among normotensive non pregnant women 19(63%) were normal 
weight, 8 [26%] were under weight, 2[6%] were overweight and 1[3%] 
were obese. The median BMI for PE women were 23.49 SD 4.49, for 
normotensive pregnant women were 23.91 SD 5.98 and normotensive 
non pregnant women were 22.20 SD 4.19. 
We compared PE groups with normal pregnant women, the p value 
is not significant.[p value 0.748] . In some recent studies observed a high 
bmi [Sahu el al., (2007), Bhattacharya et al (2007), Leeners et al., (2006)] 
among preeclampsic women. In our study we didn’t find any significant 
difference in BMI between preeclampsic and normal pregnant women. 
 
Total cholesterol 
Total cholesterol were normal for all the women with a mean 172.5 
SD 12.1 for preeclamspsic group, 192.2 SD 11.2 for, for normotensive 
pregnant women and 165.2 SD 16.7 for normotensive non pregnant 
women. On statistical analysis we found that there is no significant 
alteration in cholesterol between normotensive non pregnant women and 
preeclamspsic group. But in our study total cholesterol was significantly 
elevated in normotensive pregnant women compared to both the other 
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groups [p value<0.001]. Thus we found that there is no significant change 
in TC in PE women and the values were less when compared to 
normotensive non pregnant women. These observations are similar to 
Sattar et al (10). However some other studies observed that there is 
significant elevation in TC in women developing PE. Hubel et al, 
Adegoke et al.(11). 
 
TGL 
We observed that TGL were significantly elevated in PE women 
with a mean 222 SD 36.6 .For normotensive pregnant women mean was 
113.8 with SD of 12.1 and for normotensive non pregnant women mean 
was 113.7 with a SD of 13.1. This is one of the important finding in our 
study. On statistical analysis this was very significant with p value 
<0.001.most of the previous studies12 (Enquobahrie et al, Cekmen et al, 
Mikhail et al) observed this association and postulated that 
hypertriglyceridemia is an important factor in the pathogenesis of PE. We 
had a similar observation in our study. 
 
HDL 
In our study the mean HDL of PE women was very low (41.9 SD 
4.3) compared to both the other groups. This was found very significant 
on statistical analysis with a p value of <0.001. Normal pregnancy is 
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associate dwith an incresse in HDL ,but in our study we observed that 
HDL values were at a  lower level for normotensive pregnant women 
when compared to normal women.but this difference was not stastically 
significant [p value 0.120] . (6,7,9). This observations are consistent with 
previous studies(12) (Bradley et al, Enquobahrie et al, Cekmen et al, 
Mikhail et al). This low level of HDL is due to both hypoestrogenemia 
and insulin resistance 
 
VLDL 
We observed that, there is no significant rise in serum VLDL level 
in normotensive pregnant women compared to non pregnant women,[p 
value 0.983]. This finding is against the observations made by some 
research workers.( Knopp etal, Teichmann et al) . However the mean 
value of VLDL in PE group were very high with a mean value of 44.4 sd 
of 7.3. This was statistically very significant compared with both the 
groups, p value <0.001. This is another important observation in our 
study. This observations is very much similar to studies done by (Sattar et 
al, Kokia et al, Teichman et al). This VLDL may cause injury to the 
vascular endothelium as evident from observations of Arbogast et al. 
 73
LDL 
In our study, LDL was high in normal pregnant women compared 
to LDL in non pregnant women. [p value <0.001] .But for both the 
groups the level was under desirable limit (130 mg/dl) except for two 
women. We didn’t find any statistically significant difference in LDL 
level between PE women with both the other groups. Even though our PE 
women showed a significant increase in TGL and VLDL level there was 
no much increase in LDL level, this is similar to the observation of. 
Wakatsuki et al. 
 
TGL/ HDL RATIO. 
We have also calculated the ratio of TGL to HDL, which is thought 
to be an important predictor of the outcome of PE .in our study we 
observed that the mean  TGL/HDL ratio in PE group is  4.74 with SD of 
0.69. In normal pregnant women the mean of the ratio was 2.73 SD 0.35 
and for normal women it was 2.26 SD 0.37. On comparison this is 
statistically very significant [p value<0.001]. This observation is similar 
to the ongoing study Copenhagen Male Study (Jorgen Jeppesen et al). 
 
HDL/VLDL 
  We have also observed that there is a significant fall in ratio of 
HDL to VLDL in PE group. This is statistically very significant when 
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compared with normal pregnant women. (p value <0.001). Similar 
observations were made by so many researchers. Enquobahrie et al and 
Kokia et al. 
 
LDL/HDL RATIO AND TOTAL CHL/HDL 
We have also calculated LDL/HDL RATIO and CHL/HDL ratio. 
When compared with normal pregnant women, PE group showed a less 
value with statistically significant p value [<0.001]. This one another 
observation which is against previous studies, which showed a high value 
of this ratio in PE consistently. [ Enquobahrie et al and kokia et al] 
This variation between the ratio can be explained by the normal 
value of HDL and total CHL  in our study. We need further large scale 
study to establish the importance of this ratios in preeclampsia. 
 
Relationship between blood pressure and trglycerides 
In our study we also tried to find out the correlation of TGL level 
with blood pressure. We have observed that there is a positive correlation 
between TGL with systolic BP [r=0.822] and diastolic BP [r=0.865]. This 
is consistent with observations of Karl W et al 2003. 
Pre-eclampsia a vascular disorder of pregnancy is one of the 
leading cause of maternal morbidity  and mortality. Complications of 
hypertension are the 3rd important reason for mortality occuring in a 
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pregnant woman apart from that due to postpartum hemorrhage & 
embolism(13). Disturbed lipid metabolism, was suggested as one of the 
mechanism for the pathogenesis of PE. In our study we found that all the 
lipid sub fractions were significantly elevated, more in the case of 
triglycerides. The significant rise in serum triglyceride concentration in 
pre-eclampsia in our study was established in the studies of many 
workers (14). 
This elevation in TGL leads to increase in atherogenic small dense 
LDL concentrations. Activity of liver lipase was found as elevated in 
females with preeclampsia. This might lead to enhanced small dense low 
density lipoprotein concentration due to increased TGL exchange into 
LDL(15). Value of HDL has been observed to be reduced, which might be 
perhaps due to elevated TGL values and elevated activity of liver 
lipase.(16). 
One of the main reasons for this lipid dearrangement is due to the 
hormonal imbalance in preeclampsia. Preeclampsia is a state of 
hypoestrogenemia(17). Reduction in utero-placental blood flow is the main 
pathophysiological event in preeclampsia which leads to inappropriate 
production  of Dehydroepiandrosterone sulphate (DHEA) by fetal adrenal 
glands by interfering with the uptake and metabolisamof lipids by the 
fetus. DHEA is the most important source of estrogen in pregnancy. 90 % 
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of estrogen in a pregnant women  is from fetal DHEA. Desulphuration 
and aromatization of DHEA by the placenatal enzymes sulfatase and 
aromatase  forms estriol.(7) Because of this impairment in the formation of 
DHEA levels of estrogen in maternal blood decrease(18). Another 
mechanisam for  hypoestrogenemia is  decrease in utero-placental blood 
flow causes stasis of  blood in the intervillous space of placenta resulting 
in a decreased entry of steroids in to the maternal circulation causing 
hypoestrogenemia(19).  
This state of hypoestrogenemia causes a decresed expression of 
VLDL / apo E receptors in the placenta which are essential for the lipid 
transport to the fetus. This results in reduced transport of VLDL to fetal 
side, which could be the reason for maternal hypertriglyceridemia.  LDL 
which has to be taken up by the  growing fetus for  synthesising DHEA is 
decreased due to reduced perfusion fetoplacental unit leading to increased 
LDL. Thus a decreased catabolism of TGL by the placenta due to 
reduced blood supply and the simultaneous fall in the lipolysis of 
lipoprotein would contribute to the elevated level of triglycerides(20).  
  In a normal gestation, the formation of VLDL will be enhanced by 
estrogen. Also it plays a role in reducing the lipolysis mechanism. But 
due to the incresed VLDL/apoE receptor's expression which occurs in 
placenta, the lipoprotein are shunted to fetal circulation, meeting the 
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nutritional need of the growing fetus. Thus this elevation in triglyceride 
rich lipoprotein is physiologicaly very much imporatant for the fetus. But 
in pre-eclampsia the due to the dearrangement of placental blood supply 
TG rich lipoproteins are not cleared from circulation, exposing the 
vascular endothelium to the toxic effect. Both increased blood pressure 
and proteinuria might signify abnormal function of endothelium. Based 
on the study done by Argobast et al. It has been postulated that 
lipoproteins that are rich in triglycerides  would cause endothelial damage 
in females with PE(21). 
 
Blood  Urea 
We didn’t find any significant difference in level of urea in blood 
between the groups .Mean value of urea for PE group was 24.7 SD 5.7, 
for normal pregnancy 21.8 SD 3.4 and for normal women it was 21.5 SD 
3.1.This observations are consistent with previous studies [Lorencen et 
al]. 
 
Serum  creatinine 
Many of the old studies suggested that s.creatinine is increased in 
women with preeclampsia .However in our study there is no significant 
difference  found with S.creatinine. 
 
  
 
 
 
 
 
 
 
 
CONCLUSION 
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CONCLUSIONS 
 
1. There is no significant difference in BMI between preeclampsic 
women and normotensive pregnant women. 
2. There is no significant change in TC in PE women and the values 
were less when compared to normotensive non pregnant women. 
3. Preeclampsic women showed high level of TGL which is very 
significant (p value < 0.001) compared to both normotensive 
pregnant and nonpregnat women. 
4. Preeclampsic women showed low levels of HDL compared to 
normotensive pregnant women (p value < 0.001). 
5. Preeclampsic women showed high VLDL level, which was very 
significant (p value < 0.001) compared to both normotensive 
pregnant and nonpregnat women. 
6. There is no significant alteration in LDL level in PE women. 
7. TGL/HDL ratio was very high in Preeclampsic women, which was 
statistically significant. (p value < 0.001). 
8. HDL/VLDL ratio was low in Preeclampsic women which was 
statistically significant. (p value < 0.001). 
9. TCL/HDL ratio and LDL/HDL ratio were low when compared to 
both normotensive pregnant and nonpregnat women. 
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10. We found a highly significant positive correlation between TGL 
level and systolic BP(r=0.822) and diastolic BP(r=0.865). 
11. With this background we recommend that fasting lipid profile and 
risk ratio should be made as a part of routine antenatal checkup.  
12. We recommend further large scale population study to establish the 
importance of risk ratios and TGL as a marker of preeclampsia. 
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A COMPARATIVE STUDY OF LIPID PROFILE IN PREECLAMPSIA AND 
NORMOTENSIVE PREGNANT AND NONPREGNANT WOMEN. 
 
 
1. Name :                                                             2. Age 
3. IP/OP NO: 
4. Address                                                            5. Occupation  
6.   
G P L A 
  
7.  
N N. PRE PIH 
   
 
8.Past history  
CAD HTN DM OTHER 
    
 
9. Family history 
CAD HTN DM OTHER 
    
 
10. General examination 
R B.P R.R TEMP Wt Ht BMI 
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 11. Systemic examination 
 CVS  R.S  ABDOMEN  C.N.S 
    
 
12. Investigations                                      CBC 
HB TC DC ESR PCV PLT 
      
 
 URINE ROUTINE 
PROTEIN SUGAR CELLS OTHERS 
 
FBS PPBS B.UREA S.CREA
T 
T.BIL
RBIN 
SGO
T 
SGPT ALK.P
HO 
    D 
ID 
   
  
 FASTING LIPID PROFILE 
 
T.CHO TRIGLY
CDS 
HDL LDL VLDL 
     
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
MASTER CHART 
Master Chart 
S. No. AGE WEIGHT HEIGHT BMI Systolic BP 
Diastolic 
BP 
TCL TGL HDL 
LDL=TC–(TG/5 + 
HDL-C) 
VLDL=TG/5 BLD.UREA S.CREATNE 
1. 27 52 162 19.8 150 100 170 200 51 79 40 42 1.2 
2. 21 58 157 23.53 140 90 165 195 45 81 39 21 0.6 
3. 26 45 150 20 138 88 178 270 46 78 54 20 0.5 
4. 22 48 165 17.63 140 88 172 220 42 86 44 28 0.9 
5. 21 50 164 18.59 138 90 178 195 50 89 39 34 0.8 
6. 23 56 167 20.07 142 90 162 190 49 75 38 29 0.8 
7. 23 54 164 20.07 140 100 178 290 48 72 58 25 0.6 
8. 25 62 149 27.92 142 98 169 198 42 87 39 33 0 
9. 26 70 154 29.51 154 90 164 242 52 63 48 31 0.9 
10. 30 67 153 28.62 150 96 150 200 52 58 40 24 1 
11. 27 68 159 26.89 160 100 168 196 40 88 39 26 1 
12. 25 84 162 32.00 142 102 150 169 43 73 33 30 1 
13. 22 86 158 34.44 146 100 160 180 40 84 36 25 1 
14. 26 49 167 17.56 142 96 190 290 46 86 58 22 0.6 
15. 22 54 170 18.68 142 100 182 260 47 83 52 25 0.8 
16. 29 65 174 21.46 152 102 198 270 52 92 54 23 0.9 
17. 26 70 177 22.34 140 92 176 240 54 74 48 20 0.7 
18. 22 56 148 25.56 142 90 180 200 42 98 40 18 0.9 
19. 25 64 152 27.70 144 100 178 209 48 88 41 20 0.6 
20. 22 48 164 17.84 160 98 170 195 51 80 39 22 0.8 
21. 29 44 150 19.55 168 86 170 186 41 91 37 31 0.7 
22. 25 56 154 23.61 146 102 198 290 55 85 58 23 0.9 
23. 22 54 156 22.18 142 96 150 189 47 65 37 21 0.6 
24. 28 57 154 24.03 140 108 169 180 45 88 36 19 0.7 
25. 29 65 149 29.27 138 110 178 220 50 84 44 18 0.5 
26. 23 64 164 23.79 136 112 182 260 51 79 52 30 0.9 
27. 26 53 167 19.00 140 92 174 250 46 78 50 21 0.5 
28. 30 50 145 23.78 142 98 181 245 47 85 49 20 0.9 
29. 27 54 148 24.65 148 96 174 231 44 83 46 18 0.8 
30. 22 67 165 24.60 158 100 160 200 42 78 40 22 0.7 
31. 24 65 160 25.39 120 72 205 105 40 144 21 18 0.7 
32. 25 66 156 27.12 116 74 199 120 42 133 24 18 0.6 
33. 23 55 162 20.95 110 70 194 110 40 132 22 21 0.8 
34. 26 64 165 23.50 106 68 199 106 41 136 21 22 0.9 
35. 21 63 167 22.58 106 66 202 109 40 140 21 21 0.6 
36. 20 62 168 21.96 120 78 195 110 39 134 22 25 1 
37. 30 48 149 21.62 112 70 189 106 40 127 21 23 0.8 
38. 29 45 165 16.52 110 72 195 120 38 133 24 24 0.7 
39. 24 90 149 40.53 120 68 200 110 40 138 22 26 0.9 
40. 25 88 167 31.55 112 74 196 116 41 131 23 30 1 
41. 25 65 170 22.49 118 68 180 106 46 112 21 22 0.6 
42. 22 67 158 26.83 110 68 196 105 42 133 21 18 0.9 
43. 27 45 169 15.75 120 70 202 166 41 127 33 24 0.7 
44. 26 87 167 31.19 120 72 182 100 46 116 20 22 1 
45. 27 88 162 33.53 112 74 189 108 42 125 21 25 1 
46. 27 45 162 17.14 112 72 190 132 47 116 26 24 1 
47. 22 47 165 17.26 116 76 196 110 39 135 22 26 0.8 
48. 23 48 154 20.23 120 74 220 112 46 151 22 23 0.6 
49. 24 46 157 18.66 118 80 200 120 40 136 24 21 0.9 
50. 21 56 158 22.43 116 78 199 105 42 136 21 19 0.8 
51. 28 68 148 31.04 124 72 197 111 41 133 22 18 0.7 
52. 24 64 157 25.96 110 70 176 122 40 111 24 21 0.6 
53. 25 48 154 20.23 106 62 186 106 43 121 21 26 0.7 
54. 27 44 141 22.13 100 64 190 122 44 121 24 24 0.9 
55. 24 63 157 25.55 110 60 198 104 52 125 20 21 1 
56. 25 78 159 30.85 120 70 192 118 43 125 23 18 0.9 
57. 29 72 160 28.12 120 72 180 116 41 115 23 16 0.9 
58. 20 70 176 22.59 112 68 162 111 40 99 22 16 0.8 
59. 26 56 171 19.15 112 70 170 118 40 106 23 19 0.9 
60. 21 44 176 14.20 100 64 188 110 41 125 22 24 0.5 
61. 24 46 167 16.49 112 70 178 130 45 107 26 22 0.8 
62. 26 67 165 24.60 112 68 150 101 46 83 20 26 0.7 
63. 27 75 163 28.22 118 70 166 109 48 96 21 24 0.9 
64. 25 56 165 20.56 114 68 182 120 43 115 24 22 0.5 
65. 28 48 163 18.06 108 68 150 102 52 77 20 28 0.6 
66. 25 49 165 17.99 106 70 166 103 60 85 20 18 0.8 
67. 26 46 149 20.71 104 68 168 145 46 93 29 20 0.7 
68. 24 52 169 18.20 104 68 170 120 48 98 24 24 0.9 
69. 27 48 176 15.49 104 68 145 102 49 75 20 26 0.5 
70. 24 46 175 15.02 104 70 180 100 55 105 20 18 0.8 
71. 25 48 156 19.72 114 70 200 104 58 121 20 22 0.7 
72. 26 55 152 23.80 106 70 168 108 48 98 21 24 0.5 
73. 22 58 154 24.45 116 68 188 109 49 117 21 25 0.8 
74. 23 62 158 24.83 112 78 178 110 47 109 22 21 0.9 
75. 27 65 156 26.70 102 68 151 102 56 74 20 20 1 
76. 23 56 165 20.56 112 68 156 108 52 82 21 24 0.9 
77. 30 68 168 24.09 120 70 152 123 50 77 24 21 0.9 
78. 23 63 171 21.54 100 68 162 106 47 93 21 19 0.9 
79. 24 49 168 17.36 116 70 180 122 42 113 24 22 0.8 
80. 25 65 169 22.75 112 60 150 103 49 80 20 21 0.7 
81. 26 64 170 22.14 116 66 156 120 54 78 24 24 0.7 
82. 24 67 172 22.64 118 78 154 130 58 70 26 25 0.9 
83. 25 64 156 26.29 106 70 151 109 50 79 21 24 0.6 
84. 24 68 157 27.58 102 68 170 101 49 100 20 20 0.5 
85. 23 65 157 26.37 118 78 159 123 51 83 24 19 0.7 
86. 25 65 168 23.03 106 68 163 100 57 86 20 18 0.8 
87. 26 45 168 15.94 108 70 156 120 58 74 24 15 0.6 
88. 22 59 158 23.63 104 60 168 104 58 89 20 19 0.5 
89. 23 61 156 25.06 102 70 158 146 54 74 29 19 0.9 
90. 24 80 158 32.04 112 76 180 130 48 106 26 16 0.5 
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ABBREVIATIONS 
 
PE  - Preeclampsia 
TGL  - Triglyceride 
TC  - Total cholesterol 
FA  -  Fatty acids 
HDL  - High density lipoprotein 
LDL  - Low density lipoprotein 
VLDL - Very low density lipoprotein 
LPL  - Lipoprotein lipase 
BP  - Blood Pressure  
SD  - Standard Deviation 
 
